IBS Clinical Trials

• Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS
  ClinicalTrials.gov Identifier: NCT00179582 - Recruiting
  IBS
  
• Efficacy of Tegaserod in Relieving the Symptoms of Female Patients with Irritable Bowel Syndrome (IBS), Excluding Those with Predominant Diarrhea IBS
  ClinicalTrials.gov Identifier: NCT00142987 - Completed
  IBS-C and IBS with mixed bowel habits
  
• Effect of a Probiotic, Lactobacillus FARCIMINIS, in Diarrhea Predominant IBS Patients
  ClinicalTrials.gov Identifier: NCT00561535 - Recruiting
  Irritable Bowel Syndrome (IBS)
  
• Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in Treating Irritable Bowel Syndrome (IBS)
  ClinicalTrials.gov Identifier: NCT00194922 - Active, not recruiting
  Irritable Bowel Syndrome (IBS)
  
• Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00376896 - Recruiting
  Irritable Bowel Syndrome (IBS)
  
• Nursing Management of IBS
  ClinicalTrials.gov Identifier: NCT00167635 - Active, not recruiting
  Irritable Bowel Syndrome
  
• Development of Limited Contact CBT Treatment for IBS
  ClinicalTrials.gov Identifier: NCT00248586 - Completed
  IBS
  
• Randomized, Double-Blind, Dose-Range-Finding, Phase 2 Study of Linaclotide Administered to Patients With IBS-C
  ClinicalTrials.gov Identifier: NCT00460811 - Active, not recruiting
  Irritable Bowel Syndrome With Constipation
  
• The Effect of Probioticson Bloating in IBS
  ClinicalTrials.gov Identifier: NCT00368758 - Recruiting
  Irritable Bowel Syndrome
  
• Effect of Butyrogenic Fibers in IBS Patients
  ClinicalTrials.gov Identifier: NCT00314886 - Recruiting
  Irritable Bowel Syndrome
  
• Study to Assess the Effect Of Alosetron On Mucosal Blood Flow
  ClinicalTrials.gov Identifier: NCT00370032 - Recruiting
  Irritable Bowel Syndrome (IBS)
  
• A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
  ClinicalTrials.gov Identifier: NCT00547469 - Recruiting
  Irritable Bowel Syndrome
  
• Effect of Menstrual Cycle on CNS Processing of Gut Stimuli in IBS and Control
  ClinicalTrials.gov Identifier: NCT00219531 - Recruiting
  Irritable Bowel Syndrome
  
• Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS)
  ClinicalTrials.gov Identifier: NCT00268879 - Active, not recruiting
  Irritable Bowel Syndrome
  
• DARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in C-IBS
  ClinicalTrials.gov Identifier: NCT00220090 - Recruiting
  Irritable Bowel Syndrome
  
• Manipulation of Visceral Sensitivity and Immune System in IBS
  ClinicalTrials.gov Identifier: NCT00418340 - Not yet recruiting
  Irritable Bowel Syndrome
  
• Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
  ClinicalTrials.gov Identifier: NCT00421707 - Recruiting
  Irritable Bowel Syndrome (IBS)
  
• Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome
  ClinicalTrials.gov Identifier: NCT00316550 - Recruiting
  Irritable Bowel Syndrome (IBS)
  
• Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)
  ClinicalTrials.gov Identifier: NCT00552565 - Recruiting
  Irritable Bowel Syndrome With Diarrhea
  
• The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)
  ClinicalTrials.gov Identifier: NCT00171431 - Terminated
  Constipation Predominant - Irritable Bowel Syndrome (IBS-C)
  
• 8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS
  ClinicalTrials.gov Identifier: NCT00230581 - Completed
  Irritable Bowel Syndrome
  
• A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c
  ClinicalTrials.gov Identifier: NCT00215566 - Completed
  Irritable Bowel Syndrome With Constipation; Irritable Bowel Syndrome
  
• The Efficacy of Herbal Medicine in Relieving Symptoms and Change of Quality of Life of Patients with IBS
  ClinicalTrials.gov Identifier: NCT00153751 - Completed
  Colonic Diseases, Functional
  
• Phase 3 Study of YM060 in Patients With Diarrhea-Predominant Irritable Bowel Syndrome (d-IBS)
  ClinicalTrials.gov Identifier: NCT00189696 - Completed
  Irritable Bowel Syndrome
  
• A Study of YM060 in Diarrhea-Predominant Irritable Bowel Syndrome (d-IBS)
  ClinicalTrials.gov Identifier: NCT00189813 - Completed
  Irritable Bowel Syndrome
  
• A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS)
  ClinicalTrials.gov Identifier: NCT00394186 - Completed
  Irritable Bowel Syndrome
  
• Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy
  ClinicalTrials.gov Identifier: NCT00067457 - Completed
  Irritable Bowel Syndrome
  
• Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy
  ClinicalTrials.gov Identifier: NCT00067561 - Completed
  Irritable Bowel Syndrome
  
• A Study Designed to Evaluate the Safety and Efficacy of a Combination Herbal Therapy (CHT), Versus Placebo in Patients with Irritable Bowel Syndrome (IBS)
  ClinicalTrials.gov Identifier: NCT00130741 - Completed
  Colonic Diseases, Functional
  
• A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.
  ClinicalTrials.gov Identifier: NCT00139672 - Completed
  Irritable Bowel Syndrome
  
• Effect of Acupuncture on Symptoms of Diarrhea and Pain in IBS
  ClinicalTrials.gov Identifier: NCT00219505 - Terminated
  Irritable Bowel Syndrome
  
• Eight-Weeks of Treatment with Talnetant in Subjects with Irritable Bowel Syndrome (IBS)
  ClinicalTrials.gov Identifier: NCT00101985 - Completed
  Irritable Bowel Syndrome
  
• Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS
  ClinicalTrials.gov Identifier: NCT00258193 - Completed
  Irritable Bowel Syndrome
  
• Acupuncture for Irritable Bowel Syndrome (IBS)
  ClinicalTrials.gov Identifier: NCT00093327 - Completed
  Irritable Bowel Syndrome